These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25511758)

  • 1. Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes.
    Sarafidis PA; Bakris GL
    Nat Rev Nephrol; 2015 Feb; 11(2):70-2. PubMed ID: 25511758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.
    Marx N; Noels H; Jankowski J; Floege J; Fliser D; Böhm M
    Clin Res Cardiol; 2018 Aug; 107(Suppl 2):120-126. PubMed ID: 29728829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kidney diseases: new issues].
    Ronco P
    Presse Med; 2012 Mar; 41(3 Pt 1):240-6. PubMed ID: 22244724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Of heart and kidney: a complicated love story.
    Gaita D; Mihaescu A; Schiller A
    Eur J Prev Cardiol; 2014 Jul; 21(7):840-6. PubMed ID: 23012690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic renal disease and risk of cardiovascular morbidity-mortality.
    Santoro A; Mandreoli M
    Kidney Blood Press Res; 2014; 39(2-3):142-6. PubMed ID: 25117863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vulnerable patient with chronic kidney disease.
    Schlieper G; Hess K; Floege J; Marx N
    Nephrol Dial Transplant; 2016 Mar; 31(3):382-90. PubMed ID: 25744273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The old is new: Lipid therapy and CKD.
    Dobkowski D; Thompson ME
    JAAPA; 2015 May; 28(5):18-22. PubMed ID: 25909538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention.
    Ardhanari S; Alpert MA; Aggarwal K
    Adv Perit Dial; 2014; 30():40-53. PubMed ID: 25338421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD.
    Markossian T; Burge N; Ling B; Schneider J; Pacold I; Bansal V; Leehey D; Stroupe K; Chang A; Kramer H
    Am J Kidney Dis; 2016 Jun; 67(6):965-77. PubMed ID: 26943983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease in chronic kidney disease in 2015.
    Sud M; Naimark DM
    Curr Opin Nephrol Hypertens; 2016 May; 25(3):203-7. PubMed ID: 27023835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium and cardiovascular complications of chronic kidney disease.
    Massy ZA; Drüeke TB
    Nat Rev Nephrol; 2015 Jul; 11(7):432-42. PubMed ID: 25963594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies.
    Hung SC; Lai YS; Kuo KL; Tarng DC
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25944876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney disease and cardiovascular risk.
    Tonelli M; Pfeffer MA
    Annu Rev Med; 2007; 58():123-39. PubMed ID: 17081079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.
    Robles NR; Felix FJ; Fernandez-Berges D; Perez-Castán JF; Zaro MJ; Lozano L; Alvarez-Palacios P; Garcia-Trigo A; Tejero V; Morcillo Y; Hidalgo AB
    J Nephrol; 2013; 26(4):675-82. PubMed ID: 23100180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anemia in chronic kidney disease and its cardiovascular implications].
    Cases A; Coll E; Collado S
    Med Clin (Barc); 2009 May; 132 Suppl 1():38-42. PubMed ID: 19460479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.
    Yoda S; Nakanishi K; Tano A; Kasamaki Y; Kunimoto S; Matsumoto N; Sato Y; Hirayama A
    J Cardiol; 2012 Nov; 60(5):377-82. PubMed ID: 22890072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk prediction in chronic kidney disease: pitfalls and caveats.
    Rigatto C; Sood MM; Tangri N
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):612-8. PubMed ID: 23042027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives on CKD-induced dyslipidemia.
    Bermúdez-López M; Arroyo D; Betriu À; Masana L; Fernández E; Valdivielso JM
    Expert Opin Ther Targets; 2017 Oct; 21(10):967-976. PubMed ID: 28829206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.